rebeccamycin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anizon, F; Léonce, S; Marminon, C; Moreau, P; Pfeiffer, B; Pierré, A; Prudhomme, M; Renard, P | 1 |
Chapman, R; Cortas, T; Dowlati, A; Fu, P; Ivy, P; Levitan, N; Ness, A; Patrick, L; Remick, SC; Reynolds, S; Subbiah, S; Xu, N | 1 |
1 trial(s) available for rebeccamycin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 2005 |
1 other study(ies) available for rebeccamycin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Indoles; K562 Cells; Leukemia L1210; Lung Neoplasms; Mice; Pyrazoles; Tumor Cells, Cultured | 2002 |